Part IIOrderPublished: December 6, 2023

French Text Amended for Schedule VI

Order Amending Schedule VI to the Controlled Drugs and Substances Act (Miscellaneous Program): SOR/2023-248

This order amends the French-language text of Schedule VI to the Controlled Drugs and Substances Act by replacing item 22 of Part 1 with the wording "22Acide hypophosphoreux et ses sels et dérivés." The change was registered and came into force on 2023-11-24 and was published in the Canada Gazette on 2023-12-06; it primarily affects users of the French version of the statute.

Published
December 6, 2023
Department
Unavailable
Section
Order Amending Schedule VI to the Controlled Drugs and Substances Act (Miscellaneous Program)
Comment deadline
Unavailable
Effective date
November 24, 2023
Publication part
Part II

Summary

Summary#

This is an order, SOR/2023-248, that changes the French text of Schedule VI to the Controlled Drugs and Substances Act. It replaces one French entry (item 22 of Part 1) with the wording "22Acide hypophosphoreux et ses sels et dérivés". The order was registered and came into force on November 24, 2023 and was published in the Canada Gazette on December 6, 2023.

What it does#

  • Replaces item 22 of Part 1 of the French version of Schedule VI with the single line: 22Acide hypophosphoreux et ses sels et dérivés.
  • Comes into force on the day it was registered: November 24, 2023.
  • The notice of regulatory analysis for this change appears alongside related material following SOR/2023-247 (as noted in the Gazette).

Who's affected#

  • Primarily people and organizations that use the French-language version of the law: regulators, lawyers, courts, and anyone who reads the statute in French.
  • It may also matter to companies, laboratories, pharmacies or law-enforcement bodies that reference Schedule VI in French when checking whether a substance is listed.
  • The source does not say whether this change alters legal control of any substance or whether it simply fixes or aligns the French wording.

Why it matters#

  • It clarifies the French text of a controlled-substances list. That reduces confusion about what is covered in French-language documents and helps ensure consistent interpretation and enforcement between English and French versions of the law.
  • For people or businesses working with named chemicals, clearer bilingual listings help with compliance and documentation.

Key topics

Controlled Drugs and Substances ActCDSASchedule VIAcide hypophosphoreux et ses sels et dérivéscontrolled substanceschemical substancesHealth CanadaMinister of Mental Health and AddictionsAssociate Minister of HealthFrench-language statutebilingual legal textRegulatory Impact Analysis Statement

Source: Canada Gazette

Official source